MALLORY FALLIN: Open Payments
NPI 1548805401 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 49 payments from 13 companies in 2025. Trend: 2023 $212 · 2024 $317 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $268 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| Exact Sciences Corporation | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| Biogen, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: VRAYLAR, Auvelity, Cologuard Collection Kit, VOQUEZNA, UBRELVY, REXULTI, Wegovy, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
